Results 211 to 220 of about 2,128,989 (290)

Onychomadesis secondary to mouth, hand, and foot disease: Case report [PDF]

open access: yesBiomedica
Arredondo-Nontol R   +5 more
europepmc   +1 more source

Congenital aniridia: European COST action ANIRIDIA‐NET guidelines for diagnosis, management and care

open access: yesActa Ophthalmologica, Volume 104, Issue 3, Page 267-279, May 2026.
Abstract Congenital aniridia is a rare ocular disorder affecting the majority of eye structures and can be associated with systemic manifestations. The main visible phenotypic characteristic is the partial or complete absence of the iris; however, foveal hypoplasia is a more frequent and reliable clinical sign. Other ocular comorbidities are associated
Davide Romano   +26 more
wiley   +1 more source

Citrate‐Dependent Activation of Acetyl CoA Carboxylase Promotes Renal Lipid Accumulation in a Rat Model of Chronic Kidney Disease

open access: yesActa Physiologica, Volume 242, Issue 5, May 2026.
ABSTRACT Background Abnormal accumulation of lipids within the kidney contributes to the progression of chronic kidney disease, but the underlying metabolic mechanisms remain unclear. Citrate is a central metabolite in cellular energy regulation and is frequently elevated in advanced kidney disease, yet its impact on renal lipid metabolism has not been
Marta Sanz‐Gómez   +8 more
wiley   +1 more source

Hallazgos oftalmológicos en niños adoptados del este de Europa

open access: yes, 2019
Castillo Castejón, Olimpia   +2 more
openaire   +1 more source

Kutane Infektionen mit nicht‐tuberkulösen Mykobakterien: eine retrospektive Studie mit 94 Fällen aus Deutschland

open access: yesJDDG: Journal der Deutschen Dermatologischen Gesellschaft, Volume 24, Issue 5, Page 608-618, May 2026.
Zusammenfassung Hintergrund Kutane nichttuberkulöse Mykobakterien‐Infektionen (NTM) sind diagnostisch und therapeutisch herausfordernd. Ziel dieser Studie war die Charakterisierung kutaner NTM‐Infektionen in Deutschland über einen Zeitraum von 24 Jahren. Patienten und Methodik Eingeschlossen wurden 73 Patienten mit kutanen NTM‐Infektionen, die zwischen
Luisa Bopp   +6 more
wiley   +1 more source

Assessment of the application for modification of the terms of the authorisation of the feed additive consisting of Bacillus velezensis ATCC PTA‐6737 (PB6) for all pigs, all poultry species for fattening or reared for laying/breeding, laying hens, minor poultry species for laying and ornamental birds (Kemin Europa N.V.)

open access: yesEFSA Journal, Volume 24, Issue 5, May 2026.
Abstract Following a request from the European Commission, EFSA was asked to deliver a scientific opinion on the safety and efficacy of the preparation consisting of viable spores of Bacillus velezensis ATCC PTA‐6737 (tradename PB6). PB6 is currently authorised for use as a zootechnical additive (functional group: gut flora stabilisers) for all poultry
EFSA Panel on Additives and Products or Substances used in Animal Feed (FEEDAP)   +19 more
wiley   +1 more source

[From global strategy to local consultation: A future vision of physical activity in primary care]. [PDF]

open access: yesAten Primaria
Romaguera M   +5 more
europepmc   +1 more source

Safety evaluation of the food enzyme containing aspergillopepsin I and carboxypeptidase C activities from the non‐genetically modified Aspergillus sp. strain ACP 112–311

open access: yesEFSA Journal, Volume 24, Issue 5, May 2026.
Abstract The food enzyme with aspergillopepsin I (EC 3.4.23.18) and carboxypeptidase C (EC 3.4.16.5) activities is produced with the non‐genetically modified Aspergillus sp. strain ACP 112–311 by Shin Nihon Chemical Co., Ltd. The food enzyme was considered free from viable cells of the production organism.
EFSA Panel on Food Enzymes (FEZ)   +18 more
wiley   +1 more source

Home - About - Disclaimer - Privacy